Peng Zhi-Yong, Bishop Jeffery V, Wen Xiao-Yan, Elder Michele M, Zhou Feihu, Chuasuwan Anan, Carter Melinda J, Devlin Jason E, Kaynar A Murat, Singbartl Kai, Pike Francis, Parker Robert S, Clermont Gilles, Federspiel William J, Kellum John A
Crit Care. 2014 Jul 3;18(4):R141. doi: 10.1186/cc13969.
Prior work suggests that leukocyte trafficking is determined by local chemokine gradients between the nidus of infection and the plasma. We recently demonstrated that therapeutic apheresis can alter immune mediator concentrations in the plasma, protect against organ injury, and improve survival. Here we aimed to determine whether the removal of chemokines from the plasma by apheresis in experimental peritonitis changes chemokine gradients and subsequently enhances leukocyte localization into the infected compartment, and away from healthy tissues.
In total, 76 male adult Sprague-Dawley rats weighing 400 g to 600 g were included in this study. Eighteen hours after inducing sepsis by cecal ligation and puncture, we randomized these rats to apheresis or sham treatment for 4 hours. Cytokines, chemokines, and leukocyte counts from blood, peritoneal cavity, and lung were measured. In a separate experiment, we labeled neutrophils from septic donor animals and injected them into either apheresis or sham-treated animals. All numeric data with normal distributions were compared with one-way analysis of variance, and numeric data not normally distributed were compared with the Mann-Whitney U test.
Apheresis significantly removed plasma cytokines and chemokines, increased peritoneal fluid-to-blood chemokine (C-X-C motif ligand 1, ligand 2, and C-C motif ligand 2) ratios, and decreased bronchoalveolar lavage fluid-to-blood chemokine ratios, resulting in enhanced leukocyte recruitment into the peritoneal cavity and improved bacterial clearance, but decreased recruitment into the lung. Apheresis also reduced myeloperoxidase activity and histologic injury in the lung, liver, and kidney. These Labeled donor neutrophils exhibited decreased localization in the lung when infused into apheresis-treated animals.
Our results support the concept of chemokine gradient control of leukocyte trafficking and demonstrate the efficacy of apheresis to target this mechanism and reduce leukocyte infiltration into the lung.
先前的研究表明,白细胞的迁移是由感染病灶与血浆之间的局部趋化因子梯度决定的。我们最近证明,治疗性血液成分单采可以改变血浆中的免疫介质浓度,预防器官损伤,并提高生存率。在这里,我们旨在确定在实验性腹膜炎中通过血液成分单采从血浆中去除趋化因子是否会改变趋化因子梯度,进而增强白细胞向感染部位的定位,并使其远离健康组织。
本研究共纳入76只体重400克至600克的成年雄性Sprague-Dawley大鼠。通过盲肠结扎和穿刺诱导脓毒症18小时后,我们将这些大鼠随机分为血液成分单采组或假治疗组,持续4小时。测量血液、腹腔和肺中的细胞因子、趋化因子和白细胞计数。在另一个实验中,我们标记了脓毒症供体动物的中性粒细胞,并将其注射到血液成分单采组或假治疗组动物体内。所有呈正态分布的数值数据采用单因素方差分析进行比较,非正态分布的数值数据采用Mann-Whitney U检验进行比较。
血液成分单采显著去除了血浆中的细胞因子和趋化因子,提高了腹腔液与血液趋化因子(C-X-C基序配体1、配体2和C-C基序配体2)的比值,并降低了支气管肺泡灌洗液与血液趋化因子的比值,从而增强了白细胞向腹腔的募集并改善了细菌清除,但减少了向肺的募集。血液成分单采还降低了肺、肝和肾中的髓过氧化物酶活性和组织学损伤。当将这些标记的供体中性粒细胞注入血液成分单采治疗的动物体内时,其在肺中的定位减少。
我们的结果支持趋化因子梯度控制白细胞迁移的概念,并证明了血液成分单采针对这一机制并减少白细胞浸润到肺中的有效性。